The upregulation of Ptpn1 in tissues and cells inactivates protein tyrosine kinase (PTK), blocks the effect of insulin on binding to insulin receptors and dephosphorylation of tyrosine residues on insulin receptors substrates, leading to insulin resistance and finally to diabetes (60–62). Here, PTK2B is linked to diabetes mellitus.